Drawing for NUCLEOFECTION

USPTO serial 79246720

NUCLEOFECTION

Reviewed by CopyMark Law Group

Reg. 5864847Status 709
Filing date
Status date
Registration date
Sep 24, 2019
Examiner
MITTLER, ROBIN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUCLEOFECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence J. Crain

Lawrence J. Crain Greer, Burns & Crain, Ltd.200 West MadisonSuite 2100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical preparations for industrial and scientific use, in particular for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; chemical preparations, namely soluble substances and solutions in the nature of buffer and standard solutions, in particular for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells;diagnostic preparations and reagents for scientific or research use; biomedical compounds, namely, peptides, proteins and nucleic acids or complexes of these molecules for scientific, industrial, laboratory or research use, in particular for detecting and monitoring purposes as well as for integration of foreign nucleic acids into the genome of living cellsSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations for treating genetic defects, viral and infectious diseases, cardiovascular diseases, and cancer; diagnostic preparations for medical and veterinary use; living cells and micro-organisms as well as proteins, peptides and nucleic acids or complexes of these molecules for medical and veterinary purposes for treating genetic defects, viral and infectious diseases, cardiovascular diseases, and cancerSECTION 71 - CANCELLED—
009Scientific apparatus and instruments, namely, electroporators for generating electrical pulses, in particular for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; scientific apparatus and instruments for electroporation, namely, electroporators for introducing DNA or chromosomes into bacteria or other cells using electricity; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electroporators for introducing DNA or chromosomes into bacteria or other cells using electricity; devices, containers and reaction vessels for biochemical purposes, in particular for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells, namely, electroporation devices and vessels; test tubes; electrodes made of metal and conductive polymers; laboratory storage tubes, namely, cuvettes made of synthetic material; multi-well plates, including those having electrodes made of metal and conductive polymers, for biochemical purposes, namely, plates having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; magnetic recording carriers, namely, prerecorded magnetic data carriers featuring information for use in the field of analysis and control of biochemical processes; prerecorded floppy-disks, compact disks, DVDs and optical data carriers featuring information for use in the field of analysis and control of biochemical processes; data processing devices and computers; peripheral equipment for computers; computer programs and software for use in analyzing and controlling biochemical and biophysical processes in the field of transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells, and transient production of proteinsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 10, 2026C71TCANCELLED SECTION 71—
Dec 2, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 24, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 14, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 23, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 23, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 24, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 24, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 2, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2019ALIEASSIGNED TO LIE—
May 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 20, 2019XAECEXAMINER'S AMENDMENT ENTERED—
May 20, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 20, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
May 20, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
May 17, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 12, 2019RFNTREFUSAL PROCESSED BY IB—
Mar 19, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 19, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 10, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 9, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2019DOCKASSIGNED TO EXAMINER—
Dec 7, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 29, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance